Skip to main content
Year archive

ENTROPY NEURODYNAMICS LIMITED — 2021 filings

All 57 regulatory filings released by ENTROPY NEURODYNAMICS LIMITED (ENP) in 2021, sourced directly from the official regulator.

57 Filings
2021 Period
2021 filings (57)
Filing Released Lang
Change in substantial holding 4 pages 470.5KB
Regulatory Filings
2021-12-28 English
Exopharm Gains US Patent for LEAP Technology 3 pages 249.1KB
Regulatory Filings
2021-12-21 English
Results of Annual General Meeting 4 pages 113.0KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-24 English
Exopharm to Present at Key Exosome Industry Event 27 pages 2.4MB
Investor Presentation
2021-11-15 English
Quarterly Activities Report and Appendix 4C 11 pages 341.2KB
Interim / Quarterly Report
2021-10-26 English
2021 AGM Letter to Shareholders and Proxy 7 pages 357.4KB
AGM Information
2021-10-25 English
2021 AGM Notice of Meeting and Proxy 45 pages 1.5MB
AGM Information
2021-10-25 English
Appointment of Company Secretary 2 pages 93.3KB
Board/Management Information
2021-09-29 English
Exopharm LEAP Technology - Further Step Towards US Patent 3 pages 131.0KB
Regulatory Filings
2021-09-26 English
Response to ASX Price Query 5 pages 236.0KB
Regulatory Filings
2021-09-26 English
Exopharm LEAP Technology - Second Commercial Collaboration 3 pages 135.1KB
Capital/Financing Update
2021-09-07 English
Change of Director's Interest Notice - EM 2 pages 6.1KB
Director's Dealing
2021-09-02 English
Initial Director's Interest Notice - JK 2 pages 240.7KB
Director's Dealing
2021-08-31 English
Date of Annual General Meeting 2 pages 70.0KB
AGM Information
2021-08-31 English
Application for quotation of securities - EX1 6 pages 28.5KB
Capital/Financing Update
2021-08-31 English
Cleansing Notice 1 page 83.8KB
Share Issue/Capital Change
2021-08-31 English
Change of Director's Interest Notice - ID 2 pages 271.9KB
Director's Dealing
2021-08-31 English
Change of Director's Interest Notice - JW 2 pages 272.3KB
Director's Dealing
2021-08-31 English
Dr Jenn King joins Exopharm Board 3 pages 75.8KB
Board/Management Information
2021-08-30 English
FY2021 Appendix 4E and Annual Report 86 pages 9.8MB
Regulatory Filings
2021-08-29 English
Appendix 4G and Corporate Governance Statement 34 pages 567.5KB
Regulatory Filings
2021-08-29 English
Investor Webinar Presentation 24 pages 3.0MB
Regulatory Filings
2021-08-25 English
Investor Webinar Presentation 20 pages 2.9MB
Investor Presentation
2021-08-19 English
Notification regarding unquoted securities - EX1 7 pages 29.2KB
Share Issue/Capital Change
2021-08-01 English
Quarterly Activities Report and Appendix 4C 12 pages 360.5KB
Interim / Quarterly Report
2021-07-26 English
Update - Partnering & Licensing Focus Continues 5 pages 207.5KB
Capital/Financing Update
2021-07-01 English
Investor Presentation 21 pages 2.8MB
Investor Presentation
2021-06-29 English
Exopharm LEAP Exosome Technology Granted 1st National Patent 3 pages 282.3KB
Regulatory Filings
2021-06-02 English
Appendix 2A 17 pages 512.1KB
Share Issue/Capital Change
2021-05-05 English
Appendix 2A 15 pages 303.6KB
Capital/Financing Update
2021-04-29 English
Cleansing Notice 1 page 132.8KB
Share Issue/Capital Change
2021-04-29 English
Change in substantial holding - ID 2 pages 82.5KB
Major Shareholding Notification
2021-04-29 English
Exopharm Receives Firm Commitments to Raise $12 million 3 pages 187.5KB
Capital/Financing Update
2021-04-19 English
Proposed issue of Securities - EX1 5 pages 28.1KB
Capital/Financing Update
2021-04-19 English
Quarterly Activities Report and Appendix 4C 9 pages 468.3KB
Interim / Quarterly Report
2021-04-15 English
Investor Presentation - Delivering Transformative Medicines 17 pages 2.4MB
Investor Presentation
2021-04-15 English
Trading Halt 2 pages 212.2KB
Capital/Financing Update
2021-04-14 English
Appendix 3G 12 pages 279.1KB
Share Issue/Capital Change
2021-04-07 English
Exopharm Shareholder Update - Revenue Focus in 2021 6 pages 233.1KB
Capital/Financing Update
2021-04-07 English
Positive PLEXOVAL II Phase 1 Clinical Trial Results 4 pages 210.0KB
Regulatory Filings
2021-04-05 English
LEAP Technology- Advanced EV Medicines from Blood Components 4 pages 209.7KB
Capital/Financing Update
2021-04-05 English
Preclinical Data from Osteoarthritis Animal Study 3 pages 433.7KB
Regulatory Filings
2021-03-31 English
Securities Trading Policy 10 pages 447.2KB
Regulatory Filings
2021-03-31 English
Securities Trading Policy 10 pages 363.4KB
Regulatory Filings
2021-02-25 English
Appendix 4D and Half Year Financial Report 23 pages 703.4KB
Interim / Quarterly Report
2021-02-25 English
Exopharm presents at Bio CEO & Investor Digital Conference 27 pages 2.7MB
Investor Presentation
2021-02-15 English
Change of Director's Interest Notices - JW and ID 5 pages 509.5KB
Director's Dealing
2021-02-09 English
Substantial Shareholder notices - amendment 10 pages 489.2KB
Regulatory Filings
2021-02-08 English
Response to ASX Price and Volume Query 4 pages 491.3KB
Regulatory Filings
2021-02-07 English
Quarterly Report and Appendix 4C 11 pages 336.8KB
Interim / Quarterly Report
2021-01-28 English
Progress Points To Partnering Readiness 3 pages 318.5KB
Regulatory Filings
2021-01-20 English
Exopharm Board Changes 3 pages 407.6KB
Board/Management Information
2021-01-04 English
Final Director's Interest Notice - DP 2 pages 178.4KB
Director's Dealing
2021-01-04 English
Initial Director's Interest Notice - EM 2 pages 154.0KB
Director's Dealing
2021-01-04 English
Lapse of Performance Rights 3 pages 228.1KB
Regulatory Filings
2021-01-03 English
Becoming a substantial holder 4 pages 4.1MB
Regulatory Filings
2021-01-03 English
Change in substantial holding 3 pages 2.6MB
Regulatory Filings
2021-01-03 English